Malignant tumours of the parathyroid gland are cancerous growths that have the potential to spread (metastasize) to other parts of the body. Parathyroid carcinoma is a rare, slow-growing (indolent) tumour.
Most parathyroid tumours are functional and produce high and unregulated levels of parathyroid hormone (PTH). The over-production of PTH is called hyperparathyroidism. Less than 1% of primary hyperparathyroidism cases are caused by parathyroid carcinoma. Most cases of hyperparathyroidism are caused by parathyroid adenomas. Hyperparathyroidism leads to high levels of calcium in the blood (hypercalcemia).
Benign and malignant parathyroid tumours may cause similar signs and symptoms. Certain features suggest parathyroid carcinoma, including:
Parathyroid carcinoma is not identified with a biopsy due to the fear of tumour seeding (spreading the cancer).
Parathyroid carcinomas and adenomas (benign tumours) often look different. Malignant parathyroid tumours are usually identified during surgery based on their appearance. This is usually the most important point in proper diagnosis and treatment of parathyroid cancer.
|Parathyroid carcinoma (malignant tumour)||Parathyroid adenoma (benign tumour)|
stony or hard consistency
often gray-white in colour
red-brown in colour
oval or round in shape
between 3–3.5 cm in diameter
approximately 1.5 cm in diameter
surrounded by a thick capsule and attached or spread to nearby tissues
unattached and without spread to nearby tissues
Some parathyroid carcinomas look like adenomas, while other tumours sometimes look like parathyroid carcinoma. The diagnosis of parathyroid carcinoma must be confirmed by a pathologist, who examines the tissue using microscopy and special testing.
For cancer survivors, the Canadian Cancer Society provides a unique opportunity to celebrate their courage in the fight against cancer. During hundreds of Relay For Life events across the country, thousands of survivors join together for the Survivors’ Victory Lap.